Avidity Biosciences Stock (NASDAQ: RNA) stock price, news, charts, stock research, profile.
Open | $24.010 |
Close | $24.360 |
Volume / Avg. | 1.035M / 1.195M |
Day Range | 23.490 - 24.760 |
52 Wk Range | 4.825 - 27.660 |
Market Cap | $1.942B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 12.66% |
Days to Cover | 7.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Avidity Biosciences (NASDAQ: RNA) through any online brokerage.
Other companies in Avidity Biosciences’s space includes: Twist Bioscience (NASDAQ:TWST), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN), TG Therapeutics (NASDAQ:TGTX) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Avidity Biosciences (NASDAQ: RNA) was reported by Needham on Thursday, April 11, 2024. The analyst firm set a price target for 35.00 expecting RNA to rise to within 12 months (a possible 43.68% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Avidity Biosciences (NASDAQ: RNA) is $24.36 last updated April 26, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Avidity Biosciences.
Avidity Biosciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Avidity Biosciences.
Avidity Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.